A Phase 3 Multi-Center Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase in Adolescent Subjects (Ages 12-17) with Phenylketonuria Featuring an Open-Label Randomized Two-Arm (Active vs Diet-Only Control) Design

Grants and Contracts Details

StatusFinished
Effective start/end date8/23/228/24/23

Funding

  • BioMarin Pharma Inc: $39,075.00